RxDoctor Payments DataLook up a doctor →

Joan Merrill

Rheumatology · Oklahoma City, OKNPI 1962471813

Payments from drug & device makers

$1,810,082in general payments, 2019–2025

Across 253 payments — averaging $7154.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$617K
  • Amgen$364K
  • GSK$160K
  • Merck$125K
  • E.r. Squibb & Sons, L.L.C.$111K
  • Sanofi US Services Inc.$86K
  • plus $348K from 19 others
$516,641in research payments, 2019–2025

Across 114 payments — averaging $4531.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$286K
  • EMD Serono Research & Development Institute, Inc.$111K
  • Amgen$98K
  • Sanofi US Services Inc.$17K
  • EMD Serono, Inc.$5K
  • Eli Lilly$700
  • plus $150 from 1 others

What the payments were for

  • Consulting fees$840,85497%
  • Speaking & faculty fees$4,9751%
  • Travel & lodging$16,5422%
  • Food & beverage$1,9720%
  • Education$550%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,810,082 in reported general payments places this provider in the 90th percentile of 67 rheumatology providers in Oklahoma.

See all rheumatology providers in Oklahoma

Other rheumatology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →